Literature DB >> 27073469

Time course of various cell origin circulating microparticles in ST-segment elevation myocardial infarction patients undergoing percutaneous transluminal coronary intervention.

Boda Zhou1, Jizhao Li2, Shaomin Chen1, Enchen Zhou2, Lemin Zheng2, Lingyun Zu1, Wei Gao1.   

Abstract

The present study aimed to investigate the time course of changes in microparticles (MPs) in patients with ST-segment elevation myocardial infarction (STEMI) that underwent percutaneous transluminal coronary intervention (PCI). A total of 24 STEMI patients undergoing primary PCI were enrolled, and circulating MPs were detected immediately prior to and after PCI, and at 4, 24 and 48 h post-PCI. Standard Megamix beads, based measurement protocols, were employed to measure MPs of different cell origin, including endothelial MPs (EMPs), platelet MPs (PMPs) and leukocyte-derived MPs (LMPs), which were identified by CD144, CD41 and CD45, respectively. The results indicated that PMP levels were evidently elevated immediately after PCI, and reached a maximum level at 48 h. In addition, LMP and EMP levels were significantly decreased immediately after the PCI, and then increased gradually with time. The total quantity of the three aforementioned MP types increased gradually at 48 h following PCI. Furthermore, coronary angiographic Gensini scores were significantly positively correlated with the level of PMPs (r2=0.42; P=0.0006). Log-normalized high sensitivity-C-reactive-protein was also significantly correlated with LMPs (r2=0.86; P<0.01). In conclusion, the time course of the changes in circulating MPs of different cell origin, provided information on possible functions of different MPs in STEMI.

Entities:  

Keywords:  ST-segment elevation myocardial infarction; endothelial microparticles; leukocyte-derived microparticles; microparticle; percutaneous transluminal coronary intervention; platelet microparticles

Year:  2016        PMID: 27073469      PMCID: PMC4812389          DOI: 10.3892/etm.2016.3060

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

1.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  J Am Coll Cardiol       Date:  2011-11-07       Impact factor: 24.094

2.  Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation.

Authors:  Ewa Stępień; Elżbieta Stankiewicz; Jarosław Zalewski; Jacek Godlewski; Krzysztof Zmudka; Iwona Wybrańska
Journal:  Arch Med Res       Date:  2012-02-02       Impact factor: 2.235

3.  Distribution of C-reactive protein values in the United States.

Authors:  Steven Woloshin; Lisa M Schwartz
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

4.  Increased circulating platelet-derived microparticles are associated with stent-induced vascular inflammation.

Authors:  Teruo Inoue; Hiroshi Komoda; Norihiko Kotooka; Toshifumi Morooka; Daisuke Fujimatsu; Yutaka Hikichi; Ryoichi Soma; Toshihiko Uchida; Koichi Node
Journal:  Atherosclerosis       Date:  2007-01-17       Impact factor: 5.162

5.  Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.

Authors:  Elena I Sinauridze; Dmitry A Kireev; Nadezhda Y Popenko; Aleksei V Pichugin; Mikhail A Panteleev; Olga V Krymskaya; Fazoil I Ataullakhanov
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

Review 6.  Leukocyte-derived microparticles in vascular homeostasis.

Authors:  Anne Angelillo-Scherrer
Journal:  Circ Res       Date:  2012-01-20       Impact factor: 17.367

7.  Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men.

Authors:  L E Rohde; C H Hennekens; P M Ridker
Journal:  Am J Cardiol       Date:  1999-11-01       Impact factor: 2.778

8.  Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.

Authors:  K T Tan; M H Tayebjee; H S Lim; G Y H Lip
Journal:  Diabet Med       Date:  2005-12       Impact factor: 4.359

Review 9.  TIMI grade flow, mortality, and the GUSTO-III trial.

Authors:  K A Stringer
Journal:  Pharmacotherapy       Date:  1998 Jul-Aug       Impact factor: 4.705

10.  Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis.

Authors:  K Handa; S Kono; K Saku; J Sasaki; T Kawano; Y Sasaki; T Hiroki; K Arakawa
Journal:  Atherosclerosis       Date:  1989-06       Impact factor: 5.162

View more
  1 in total

Review 1.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.